biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs > I Don’t Know About The Rest Of You b But ….

<< Previous

Bullboard Posts

Next >>

Comment by Boomskidon Aug 25, 2023 12:38am

60 Views

Post# 35604834

RE:I Don’t Know About The Rest Of You b But ….

Hah! You think you're tired of it, beenthere...

I'm pretty much done until the endgame. And TT ran out of material about 90 posts ago.

I think that things needed to be said, put on the record, pushed out to Bioasis, to Rathjen, memorialized, that she doesn't work in a vacuum, that she's rather obvious when she's trying to be obscure and clever.

Bioasis has been the worst long term continuing experience of my life and it's been really hard to come back from it.

But I am. It's good.

Later, later...

jd

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario